## Benzodiazepine Selection in Hepatic Impairment **Key Point:** In patients with liver disease, lorazepam is preferred because it undergoes hepatic conjugation (not oxidation) and produces no active metabolites, reducing the risk of drug accumulation and hepatic encephalopathy. ### Metabolism Pathways | Benzodiazepine | Metabolism | Active Metabolites | Hepatic Clearance | Use in Cirrhosis | | --- | --- | --- | --- | --- | | **Lorazepam** | Conjugation | None | Preserved | ✓ Preferred | | **Diazepam** | Oxidation | Yes (desmethyldiazepam) | Impaired | ✗ Avoid | | **Chlordiazepoxide** | Oxidation | Yes (multiple) | Impaired | ✗ Avoid | | **Midazolam** | Oxidation | Yes | Severely impaired | ✗ Contraindicated | ### Why Lorazepam is Superior in Cirrhosis 1. **Conjugation pathway** — independent of hepatic oxidative metabolism; remains effective even in advanced liver disease 2. **No active metabolites** — eliminates risk of accumulation and prolonged sedation 3. **Lower risk of encephalopathy** — avoids benzodiazepine-induced hepatic encephalopathy worsening 4. **Predictable pharmacokinetics** — half-life and clearance are not significantly altered by cirrhosis **High-Yield:** Oxidatively metabolized benzodiazepines (diazepam, chlordiazepoxide, midazolam) accumulate in cirrhosis and precipitate or worsen hepatic encephalopathy—a critical trap in exams. ### Clinical Pearl Even though chlordiazepoxide is historically used in alcohol withdrawal protocols, it is contraindicated in patients with cirrhosis. Lorazepam is the universal choice for AWS in any degree of hepatic impairment. [cite:KD Tripathi 8e Ch 14; Harrison 21e Ch 391]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.